
|Articles|September 1, 2002
- Volume 0 0
Childhood Asthma Rates May Have Plateaued
Advertisement
The rising asthma rates in children over the past several years may have plateaued, researchers from the Centers for Disease Control and Prevention reported recently in Pediatrics. The asthma rate among children increased from 3.6% to 6.3% from 1980 to 1996. The rate was 5.4% in 1997 and remained stable through 2000. Nevertheless, African-American children had the highest risk throughout the study period, and ethnic disparities in asthma health care utilization and mortality remain.
Articles in this issue
about 24 years ago
Seperate Powders??about 24 years ago
Pure testosterone isocaproate powder...about 24 years ago
Delivery of progesterone...about 24 years ago
Try a Little Exerciseabout 24 years ago
Seasonal Affective Disorderabout 24 years ago
Most Asthmatics Are Not Using Anti-inflammatory Drugsabout 24 years ago
New Guidelines on Inhaler Packaging Are Issuedabout 24 years ago
Big Babies Have Reduced Diabetes Riskabout 24 years ago
Niacin Therapyabout 24 years ago
Whole-Grain HealthAdvertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


